Iron accumulation in the substantia nigra in rats visualized by ultrasound

Ultrasound in Medicine and Biology

Volumn 25, Issue 6, 1999, Pages 901-904

  Berg, Daniela ^a   Grote, Christoph ^c   Rausch, Wolf Dieter ^d   Mäurer, Mattias ^a   Wesemann, Wolfgang ^c   Riederer, Peter ^b   Becker, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Institute of Clinical Neurochemistry   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

6 OHDA; Animal model; Desferrioxamine; Ferritin; Iron; Protein bound iron; Spectroscopy; Substantia nigra; Transcranial ultrasound; Ultrasound

Indexed keywords

BIOCHEMISTRY; BRAIN; IRON; ORGANIC COMPOUNDS; PATIENT MONITORING; PROTEINS; SPECTROSCOPY;

ANIMAL MODEL; DESFERRIOXAMINE; FERRITIN; PROTEIN BOUND IRON; RATS; SUBSTANTIA NIGRA; TRANSCRANIAL ULTRASOUND;

ULTRASONIC IMAGING;

IRON; IRON BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIAGNOSTIC VALUE; IMAGE ANALYSIS; IRON METABOLISM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ULTRASOUND;

ANIMALS; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRITINS; HUMANS; IRON; OXIDOPAMINE; PARKINSON DISEASE; PILOT PROJECTS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; ZINC;

EID: 0032765888     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(99)00046-0     Document Type: Article

References (29)

1. Barron K.D. The microglial cell. A historical review. J Neurol Sci. 134:(Suppl.):1995;57-68.
2. Becker G., Bogdahn U. Transcranial color-coded real-time sonography. Babikian V.L., Wechsler L.R. Transcranial Doppler ultrasonography. 1993;51-66 Mosby Year Book, St. Louis.
3. Becker G., Seufert J., Bogdahn U., Reichmann H., Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology. 45:1995;182-184.
4. Ben-Shachar D., Eshel G., Finberg J.P.M., Youdim M.B.H. The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem. 56:1991;1441-1444.
5. Bogdahn U., Winkler J., Schwab S., Adolf H. Parenchymanatomie. Bogdahn U., Becker G., Schlachetzki F. Echosignalverstärker und transkranielle Farbduplex-Sonographie. 1998;233-250 Blackwell Wissenschafts-Verlag, Berlin.
6. Connor J.R., Menzies S.L., Martin S.M., Mufson E.J. Cellular distribution of transferrin, ferritin and iron in normal and aged human brains. J Neurosci Res. 27:1990;595-611.
7. Dexter D.T., Carayon A., Javoy-Agid F., et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 114:1991;1953-1975.
8. Dexter D.T., Sian J., Jenner P., Marsden C.D. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. Adv Neurol. 60:1993;273-281.
9. Dexter D.T., Wells F.R., Lees A.J., et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem. 52:1989;1830-1836.
10. Double K.L., Maywald M., Schmittel M., Riederer P., Gerlach M. In vitro studies of ferritin iron release and neurotoxicity. J Neurochem. 6:1998;2492-2499.
11. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem. 63:1994;793-807.
12. Gerlach M., Riederer P. Animal models of Parkinson's disease an empirical comparison with the phenomenology of the disease in man . J Neural Trnasm. 103:1996;987-1041.
13. Hallgren B., Sourander P. The effect of age on the nonhaem iron in the human brain. J Neurochem. 3:1958;41-51.
14. Hill JM. Brain iron in the rat: distribution, sex differences and effects of sex hormones. Ph.D. thesis. Ann Arbor, MI: Michigan State University, 1982.
15. Hirsch E.C., Brandel J.P., Galle P., Javoy-Agid F., Agid Y. Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease An x-ray microanalysis . J Neurochem. 56:1991;446-451.
16. Leveugle B., Faucheux B.A., Bouras C., et al. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol. 91:1996;566-572.
17. Linert W., Herlinger E., Jameson R.F., et al. Dopamine, 6-hydroxydopamine, iron, and dioxygen - their mutual interactions and possible implication in the development of Parkinson's disease. Biochim Biophys Acta. 1316:1996;160-168.
18. Monterio H.P., Winterbourne C.C. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem Pharmacol. 38:1989;4144-4182.
19. Montine T.J., Farris D.B., Graham D.G. Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J Neuropathol Exp Neurol. 54:1995;311-319.
20. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, New York.
21. Riederer P., Sofic E., Rausch W.D., et al. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem. 52:1989;515-520.
22. Sengstock G.J., Olanow C.W., Menzies R.A., Dunn A.J., Arendash G.W. Infusion of iron into the rat substantia nigra Nigral pathology and dose-dependent loss of striatal dopaminergic markers . J Neurosci Res. 35:1993;67-82.
23. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B.H. Selective increase of iron in the substantia nigra zona compacta of parkinsonian brains. J Neurochem. 56:1991;978-982.
24. Sofic E., Riederer P., Heinsen H., et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm. 74:1988;199-205.
25. Spatz H. Über den Eisennachweis im Gehirn, besonders in Zentren des extra-pyramidal-motorischen Systems. Z Neurol Psychiat. 77:1922;261-290.
26. Tingey A.H. The iron, copper and manganese content of the human brain. J Ment Sci. 83:1977;451-460.
27. Wang X, Manganaro F, Schipper HM. A cellular stress model for the sequestration of redox-active glial iron in the the aging and degenerating nervous system. J Neurochem 1995;64:1968-1877.
28. Willson R.L. Iron, zinc, free radicals and oxygen in tissue disorders and cancer control. Porter R., Fitzsimons D.W. Iron metabolism. Ciba Foudation Symposium 51. 1977;331-354 Elsevier, Amsterdam and Oxford.
29. Youdim M.B.H., Ben-Shachar D., Eshel G., Finberg J.P.M., Riederer P. The neurotoxicity of iron and nitric oxide. Adv Neurol. 60:1993;259-265.